Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vantage Data Centers designs and develops data center campuses to large cloud providers, AI enterprises, and other tech-driven businesses.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
AgroStar is an agritech company that offers agribusiness farming, rural e-commerce and retail services.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Luminance provides an AI-powered platform for contract generation, negotiation, and post-execution analysis using legal-focused models.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Araris Biotech is a biotechnology company that develops antibody-drug conjugates for efficient payload attachment.
Healthy Workers makes employee well-being measurable.
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.
Schroders Capital has invested in 40 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Schroders Capital's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Biopharma. The firm invests across 27 different industry categories.
Among tracked funding rounds, Eikon Therapeutics received $350.7M in a Series D round. Schroders Capital's total known invested capital is $6.4B.
Schroders Capital's average investment size is $152.7M across its portfolio of 40 companies.
Recent Schroders Capital portfolio additions include Vantage Data Centers, Kinaset Therapeutics, AgroStar, Artios Pharma, AAVantgarde Bio. These companies were founded in 2020 or later.